CD36 and metabolic dysfunction-associated steatohepatitis: For instance, what are the molecular mechanisms involved in liver-specific regulation of CD36 expression or function, and how does this impact on hepatic lipotoxicity thus influencing progression from hepatosteatosis to NASH?